← Back to Screener
Drugs Made In America Acquisition Corp. Units (DMAAU)
Price$10.58
Favorite Metrics
Price vs S&P 500 (26W)-6.51%
Price vs S&P 500 (4W)-8.92%
Market Capitalization$355.04M
All Metrics
Book Value / Share (Quarterly)$6.87
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.02
Price vs S&P 500 (YTD)-2.11%
EPS (TTM)$0.20
10-Day Avg Trading Volume0.43M
EPS Excl Extra (TTM)$0.20
EPS (Annual)$-0.01
Cash / Share (Quarterly)$0.00
P/E Basic Excl Extra (TTM)65.17x
ROA (Last FY)-50.81%
EBITD / Share (TTM)$-0.04
Cash Flow / Share (Annual)$-0.01
P/B Ratio1.54x
P/B Ratio (Quarterly)1.49x
ROA (TTM)3.09%
EPS Incl Extra (Annual)$-0.01
Current Ratio (Annual)0.01x
Quick Ratio (Quarterly)0.00x
3-Month Avg Trading Volume0.10M
P/E Incl Extra (TTM)65.17x
52-Week High$10.55
EPS Excl Extra (Annual)$-0.01
26-Week Price Return2.23%
Quick Ratio (Annual)0.00x
13-Week Price Return1.63%
Current Ratio (Quarterly)0.06x
Enterprise Value$355.041
Cash / Share (Annual)$0.00
3-Month Return Std Dev2.50%
EPS Basic Excl Extra (Annual)$-0.01
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$0.20
Revenue / Share (Annual)$0.00
P/E Ratio (TTM)65.17x
Year-to-Date Return1.50%
5-Day Price Return0.19%
EPS Normalized (Annual)$-0.01
Month-to-Date Return0.48%
EBITD / Share (Annual)$-0.01
P/E Excl Extra (TTM)65.17x
EPS Basic Excl Extra (TTM)$0.20
Price vs S&P 500 (13W)-1.24%
Beta-0.00x
Revenue / Share (TTM)$0.00
52-Week Low$10.03
Industry Peers — Blank Checks / SPACs(334)
| Symbol | P/E Ratio (Annual) | Indicated Dividend Yield (Annual) | ROE (TTM) | P/B Ratio (Quarterly) | Price |
|---|---|---|---|---|---|
DMAAUDrugs Made In America Acquisition Corp. Units | — | — | — | 1.49x | $10.58 |
LFACLeapfrog Acquisition Corporation Class A Ordinary Shares | 742.60x | — | 1.92% | 2.80x | $9.95 |
LFACULeapfrog Acquisition Corporation Units | 720.81x | — | 1.92% | 2.80x | $10.04 |
AACIArmada Acquisition Corp. III Class A Ordinary Share | — | — | -9.52% | 14.61x | $9.90 |
BEAGBold Eagle Acquisition Corp. Class A Ordinary Shares | 61.97x | — | 3.80% | 2.33x | $10.53 |
BEAGRBold Eagle Acquisition Corp. Right | 61.97x | — | 3.80% | 2.33x | $0.24 |
BEAGUBold Eagle Acquisition Corp. Units | 61.97x | — | 3.80% | 2.33x | $10.74 |
BCSSBain Capital GSS Investment Corp. | 139.43x | — | — | 1.31x | $10.18 |
BCSS.UBain Capital GSS Investment Corp. Units, each consisting of one Class A Ordinary Share and one-fifth of one redeemable warrant | 139.43x | — | — | 1.31x | $10.39 |
CEPFCantor Equity Partners IV, Inc. Class A Ordinary Shares | 95.72x | — | — | 1.29x | $10.26 |
KRSPRice Acquisition Corporation 3 | 172.51x | — | — | 1.41x | $10.30 |
About
Drugs Made In America Acquisition Corp. is a special purpose acquisition company (SPAC) formed to identify, acquire, and operate a business in the pharmaceutical or healthcare sector. The company seeks to combine with a domestic drug manufacturer or related healthcare enterprise through a merger or acquisition. It provides investors with exposure to the U.S. pharmaceutical industry through a structured business combination transaction.